Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37336468)
Watch
English
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings.
scientific article published on December 2008
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
main subject
multiple myeloma
1 reference
based on heuristic
inferred from title
author
Enrique M Ocio
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
Patricia Maiso
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
Jesús San Miguel
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
Atanasio Pandiella
series ordinal
4
object named as
Atanasio Pandiella
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
author name string
María-Victoria Mateos
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
publication date
1 December 2008
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
volume
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
issue
12
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
page(s)
1157-1165
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
cites work
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of imatinib in patients with refractory/relapsed myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CHIR-258 is efficacious in a newly developed fibroblast growth factor receptor 3-expressing orthotopic multiple myeloma model in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
GW654652, the pan-inhibitor of VEGF receptors, blocks the growth and migration of multiple myeloma cells in the bone marrow microenvironment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetics and cytogenetics of multiple myeloma: a workshop report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting aurora kinases as therapy in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970304-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(08)70304-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
PubMed publication ID
19038762
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19038762
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19038762%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit